In agreement with this, MMRd CRCs display strong TLS signatures and have a significant presence of CXCL13-expressing T cells throughout the tumor and CXCL13-expressing follicular DCs in TLSs (43, 170). This evidence concerns the gene CXCL13 and neoplasm.